{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:56:45Z","timestamp":1788929805831,"version":"build-2803163510"},"reference-count":95,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research","award":["142329"],"award-info":[{"award-number":["142329"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The risk of idiosyncratic drug-induced agranulocytosis (IDIAG) markedly constrains the use of clozapine, a neuroleptic with unparalleled efficacy. Most clozapine patients experience an early inflammatory response, likely a necessary step in IDIAG onset. However, most patients do not progress to IDIAG, presumably because of the requirement of specific human leukocyte antigen (HLA) haplotypes, T cell receptors, and other unknown factors. We established that clozapine activates inflammasomes and that myeloperoxidase bioactivation of clozapine generates neoantigens, but the connection between these early mechanistic events remained unknown and, thus, was the aim of this work. We found that the myeloperoxidase inhibitor PF-1355 attenuated myeloperoxidase activity in phorbol myristate acetate (PMA)-differentiated THP-1 macrophages, and it also attenuated clozapine-induced release of inflammatory mediators (e.g., IL-1\u03b2, CXCL1, and C-reactive protein). In vivo, pretreatment of Sprague Dawley rats with PF-1355 significantly attenuated clozapine-induced increases in neutrophil mobilization from the bone marrow to the blood and spleen, as determined using differential blood counts and flow cytometry. Moreover, the clozapine-triggered release of inflammatory mediators (e.g., IL-1\u03b2, calprotectin, CXCL1, and \u03b1-1-acid glycoprotein) from the liver, spleen, and bone marrow was dampened by myeloperoxidase inhibition. These data support the working hypothesis that oxidation of clozapine to a reactive metabolite by myeloperoxidase is critical for induction of the inflammatory response to clozapine. Ultimately, a better mechanistic understanding of the early events involved in the immune response to clozapine may elucidate ways to prevent IDIAG, enabling safer, more frequent therapeutic use of this and potentially other highly efficacious drugs.<\/jats:p>","DOI":"10.3390\/ijms24021243","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:09:39Z","timestamp":1673230179000},"page":"1243","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0904-8516","authenticated-orcid":false,"given":"Samantha Christine","family":"Sernoskie","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-0002","authenticated-orcid":false,"given":"Alison","family":"Jee","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Uetrecht","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"},{"name":"Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmj.2.4621.261","article-title":"Leucocyte counts in the prevention of drug agranulocytosis","volume":"2","author":"Young","year":"1949","journal-title":"Br. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14740338.2017.1376645","article-title":"Non-chemotherapy drug-induced neutropenia\u2014An update","volume":"16","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_5","first-page":"e1973","article-title":"Clozapine: Improvement of Negative Symptoms of Schizophrenia","volume":"9","author":"Khan","year":"2017","journal-title":"Cureus"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3389\/fphar.2018.01049","article-title":"Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis","volume":"9","author":"Numata","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: A clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0000000000000478","article-title":"Clozapine Underutilization in the Treatment of Schizophrenia","volume":"36","author":"Bogers","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: Balancing Safety with Superior Antipsychotic Efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0000000000000904","article-title":"Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service","volume":"38","author":"Inada","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0897190014546115","article-title":"Nonchemotherapy drug-induced neutropenia and agranulocytosis: Could medications be the culprit?","volume":"27","author":"Pick","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/asheducation-2017.1.187","article-title":"Non-chemotherapy drug-induced neutropenia: Key points to manage the challenges","volume":"2017","author":"Curtis","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/YCO.0000000000000440","article-title":"Clozapine pharmacogenomics: A review of efficacy, pharmacokinetics, and agranulocytosis","volume":"31","author":"Li","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: Recent advances, challenges and future perspective","volume":"20","author":"Legge","year":"2019","journal-title":"Pharmacogenomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4049\/jimmunol.2000646","article-title":"Characterization of Clozapine-Responsive Human T Cells","volume":"205","author":"Ogese","year":"2020","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2016.12.003","article-title":"Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach","volume":"316","author":"Regen","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JCP.0000000000001329","article-title":"Clozapine Response in Schizophrenia and Hematological Changes","volume":"41","author":"Blackman","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactionss","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/tx500184c","article-title":"Clozapine promotes the proliferation of granulocyte progenitors in the bone marrow leading to increased granulopoiesis and neutrophilia in rats","volume":"27","author":"Lobach","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/tx500183x","article-title":"Effect of Clozapine and Olanzapine on Neutrophil Kinetics: Implications for Drug-Induced Agranulocytosis","volume":"27","author":"Ng","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine Induces an Acute Proinflammatory Response That Is Attenuated by Inhibition of Inflammasome Signaling: Implications for Idiosyncratic Drug-Induced Agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","article-title":"Mechanism of clozapine-induced agranulocytosis: Current status of research and implications for drug development","volume":"7","author":"Pirmohamed","year":"1997","journal-title":"CNS Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/tx100035k","article-title":"Effect of clozapine on neutrophil kinetics in rabbits","volume":"23","author":"Iverson","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.leu.2402514","article-title":"Functional activity of three distinct myeloperoxidase (MPO) promoters in human myeloid cells","volume":"16","author":"Lin","year":"2002","journal-title":"Leukemia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0145-2126(96)00032-X","article-title":"Control of myeloperoxidase gene expression in developing myeloid cells","volume":"20","author":"Austin","year":"1996","journal-title":"Leuk. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx500019u","article-title":"Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: Implications for drug-induced agranulocytosis","volume":"27","author":"Lobach","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2018.01.004","article-title":"Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function","volume":"640","author":"Aratani","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0300-483X(93)90066-2","article-title":"Myeloperoxidase-mediated activation of xenobiotics by human leukocytes","volume":"82","author":"Hofstra","year":"1993","journal-title":"Toxicology"},{"key":"ref_30","first-page":"1476","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","first-page":"846","article-title":"Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis","volume":"40","author":"Fischer","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"ref_32","first-page":"999","article-title":"A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_33","first-page":"991","article-title":"A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Uetrecht, J.P., and Trager, W. (2007). Reactive metabolites. Drug Metabolism: Chemical and Enzymatic Aspects, CRC Press, Taylor & Francis.","DOI":"10.3109\/9780849375965"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.114.221788","article-title":"PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti-Glomerular Basement Membrane Glomerulonephritis","volume":"353","author":"Zheng","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jacbts.2016.09.004","article-title":"Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction","volume":"1","author":"Ali","year":"2016","journal-title":"JACC Basic to Transl. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2007-979495","article-title":"The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels","volume":"30","author":"Fenzel","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollmacher","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0b013e32833643fd","article-title":"Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients","volume":"25","author":"Fehsel","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000507638","article-title":"A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology","volume":"89","author":"Ruan","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"ref_41","first-page":"6457","article-title":"Risks and Benefits of Rapid Clozapine Titration","volume":"8","author":"Lochhead","year":"2016","journal-title":"Ment. Illn."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3371\/1935-1232.10.3.163","article-title":"A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns","volume":"10","author":"Citrome","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfi014","article-title":"Modeling and Predicting Stress-Induced Immunosuppression in Mice Using Blood Parameters","volume":"83","author":"Schwab","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00915049","article-title":"Corticosteroid effects on circulating lymphocyte subset levels in normal humans","volume":"4","author":"Zweiman","year":"1984","journal-title":"J. Clin. Immunol."},{"key":"ref_45","first-page":"669","article-title":"Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow","volume":"28","author":"Fauci","year":"1975","journal-title":"Immunology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e001019","DOI":"10.1136\/jitc-2020-001019","article-title":"Early changes in immune cell subsets with corticosteroids in patients with solid tumors: Implications for COVID-19 management","volume":"8","author":"Toney","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0003-9861(62)90321-1","article-title":"Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization","volume":"96","author":"Schultz","year":"1962","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0005-2744(78)90197-3","article-title":"Characterization and quantification of the peroxidase in human monocytes","volume":"525","author":"Bos","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.3389\/fimmu.2021.780210","article-title":"Extracellular CIRP Induces Macrophage Extracellular Trap Formation Via Gasdermin D Activation","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"102109","DOI":"10.1016\/j.redox.2021.102109","article-title":"The many roles of myeloperoxidase: From inflammation and immunity to biomarkers, drug metabolism and drug discovery","volume":"46","author":"Siraki","year":"2021","journal-title":"Redox Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/acs.chemrestox.2c00008","article-title":"Neutrophil Myeloperoxidase-Mediated N-Demethylation of Quetiapine Leads to N-Desalkylquetiapine, a Pharmacologically Active Cytochrome P450 Metabolite","volume":"35","author":"Rashid","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1021\/tx5001333","article-title":"Activation of Inflammasomes by Agents Causing Idiosyncratic Skin Reactions: A Possible Biomarker","volume":"27","author":"Weston","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105063","DOI":"10.1016\/j.tiv.2020.105063","article-title":"Activation of inflammasomes by tyrosine kinase inhibitors of vascular endothelial growth factor receptor: Implications for VEGFR TKIs-induced immune related adverse events","volume":"71","author":"Imano","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/acs.chemrestox.1c00127","article-title":"Amiodarone, Unlike Dronedarone, Activates Inflammasomes via Its Reactive Metabolites: Implications for Amiodarone Adverse Reactions","volume":"34","author":"Kato","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2131\/jts.45.673","article-title":"Reactive metabolite of gefitinib activates inflammasomes: Implications for gefitinib-induced idiosyncratic reaction","volume":"45","author":"Kato","year":"2020","journal-title":"J. Toxicol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.chemrestox.7b00065","article-title":"Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes","volume":"30","author":"Kato","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/dmd.119.087981","article-title":"The 2-Hydroxyiminostilbene metabolite of carbamazepine or the supernatant from incubation of hepatocytes with carbamazepine activates inflammasomes: Implications for carbamazepine-induced hypersensitivity reactions","volume":"47","author":"Kato","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and Inflammatory Functions of the Interleukin-1 Family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41232-019-0101-5","article-title":"The role of interleukin-1 in general pathology","volume":"39","author":"Kaneko","year":"2019","journal-title":"Inflamm. Regen."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Barnett-Vanes, A., Sharrock, A., Birrell, M.A., and Rankin, S. (2016). A Single 9-Colour Flow Cytometric Method to Characterise Major Leukocyte Populations in the Rat: Validation in a Model of LPS-Induced Pulmonary Inflammation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0142520"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3389\/fimmu.2021.674079","article-title":"Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation","volume":"12","author":"Bongers","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.4049\/jimmunol.176.7.4155","article-title":"Relationships between Distinct Blood Monocyte Subsets and Migrating Intestinal Lymph Dendritic Cells In Vivo under Steady-State Conditions","volume":"176","author":"Yrlid","year":"2006","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Sprenkeler, E.G.G., Zandstra, J., van Kleef, N.D., Goetschalckx, I., Verstegen, B., Aarts, C.E.M., Janssen, H., Tool, A.T.J., van Mierlo, G., and van Bruggen, R. (2022). S100A8\/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation. Cells, 11.","DOI":"10.3390\/cells11020236"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Polkowska-Pruszy\u0144ska, B., Gerkowicz, A., Rawicz-Pruszy\u0144ski, K., and Krasowska, D. (2020). The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO). Diagnostics, 10.","DOI":"10.3390\/diagnostics10080587"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","article-title":"Serum calprotectin: A promising biomarker in rheumatoid arthritis and axial spondyloarthritis","volume":"22","author":"Jarlborg","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: From biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"key":"ref_67","first-page":"245","article-title":"Calprotectin-a Pleiotropic Molecule in Acute and Chronic Inflammation","volume":"53","year":"2004","journal-title":"Physiol. Res"},{"key":"ref_68","first-page":"125","article-title":"Fluperlapine in 104 schizophrenic patients. Open multicenter trial","volume":"34","year":"1984","journal-title":"Arzneimittelforschung."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00002018-199200071-00011","article-title":"Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis","volume":"7","author":"Uetrecht","year":"1992","journal-title":"Drug Saf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/kfq392","article-title":"Involvement of T Helper 17 Cells in D-Penicillamine-Induced Autoimmune Disease in Brown Norway Rats","volume":"120","author":"Zhu","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/tx00020a015","article-title":"N-Chlorination and oxidation of procainamide by myeloperoxidase: Toxicological implications","volume":"4","author":"Uetrecht","year":"1991","journal-title":"Chem. Res. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/tx00001a013","article-title":"Metabolism of Procainamide to a Hydroxylamine by Human Neutrophils and Mononuclear Leukocytes","volume":"1","author":"Rubin","year":"1988","journal-title":"Chem. Res. Toxicol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0006-2952(95)00236-S","article-title":"The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: Chemical mechanisms and the effects of fluorine substitution","volume":"50","author":"Tingle","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0009-2797(90)90009-C","article-title":"Myeloperoxidase catalysed cooxidative metabolism of methimazole: Oxidation of glutathione and NADH by free radical intermediates","volume":"73","author":"McGirr","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","article-title":"How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction","volume":"30","author":"Cho","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2018.11.031","article-title":"The development of myeloperoxidase inhibitors","volume":"29","author":"Galijasevic","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lockhart, J.S., and Sumagin, R. (2022). Non-Canonical Functions of Myeloperoxidase in Immune Regulation, Tissue Inflammation and Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012250"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/br.2022.1536","article-title":"Role of myeloperoxidase in inflammation and atherosclerosis","volume":"16","author":"Frangie","year":"2022","journal-title":"Biomed. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/rheumatology\/kes193","article-title":"Myeloperoxidase and oxidative stress in rheumatoid arthritis","volume":"51","author":"Stamp","year":"2012","journal-title":"Rheumatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1069743","DOI":"10.1155\/2016\/1069743","article-title":"Role of Myeloperoxidase in Patients with Chronic Kidney Disease","volume":"2016","author":"Kisic","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2018.03.012","article-title":"Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease","volume":"645","author":"Chami","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hawkins, C., and Nauseef, W.M. (2021). The Role of Myeloperoxidase in Neurodegenerative Disease. Mammalian Heme Peroxidases: Diverse Roles in Health and Disease, CRC Press.","DOI":"10.1201\/9781003212287"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/13543776.2020.1780210","article-title":"A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013\u20132019)","volume":"30","author":"Soubhye","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/tx015548d","article-title":"Hypochlorite-induced damage to DNA, RNA, and polynucleotides: Formation of chloramines and nitrogen-centered radicals","volume":"15","author":"Hawkins","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/abbi.1996.0322","article-title":"Hypochlorous Acid Interactions with Thiols, Nucleotides, DNA, and Other Biological Substrates","volume":"332","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.ATV.0000148703.43429.25","article-title":"2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein\u2013Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis","volume":"24","author":"Marsche","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_87","first-page":"251","article-title":"A Study of Ligand Binding to Spleen Myeloperoxidase","volume":"26","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/ars.2020.8030","article-title":"The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease","volume":"32","author":"Davies","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000480373","article-title":"Macrophage Extracellular Traps: A Scoping Review","volume":"10","author":"Doster","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fimmu.2012.00420","article-title":"The expanding world of extracellular traps: Not only neutrophils but much more","volume":"3","author":"Goldmann","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.40372","article-title":"Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation","volume":"70","author":"Schwartz","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"De Abreu Costa, L., Henrique Fernandes Ottoni, M., Geralda dos Santos, M., Batista Meireles, A., Gomes de Almeida, V., de F\u00e1tima Pereira, W., Alves de Avelar-Freitas, B., and Eust\u00e1quio Alvim Brito-Melo, G. (2017). Dimethyl Sulfoxide (DMSO) Decreases Cell Proliferation and TNF-\u03b1, IFN-\u03b3, and IL-2 Cytokines Production in Cultures of Peripheral Blood Lymphocytes. Molecules, 22.","DOI":"10.3390\/molecules22111789"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0924-977X(99)00033-4","article-title":"Cytochrome P450 and therapeutic drug monitoring with respect to clozapine","volume":"9","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jlb.54.1.47","article-title":"Differential surface expression of cell adhesion molecules during granulocyte maturation","volume":"54","author":"Terstappen","year":"1993","journal-title":"J. Leukoc. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1243\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:31Z","timestamp":1760119411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,8]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021243"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021243","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,8]]}}}